Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela Merkely

Showing results (261-270 of 296) with videos related to

Pageof 30
Sort By:
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
European Heart Journal|November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failureJohn McMurray, Milton Packer, Akshay Desai, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 28, 2025
The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratiosKevin M Veen, Mazen Ahmed, Christoffer Stark, et al.
Pageof 30

Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.
European Heart Journal|November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failureJohn McMurray, Milton Packer, Akshay Desai, et al.
European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 28, 2025
The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratiosKevin M Veen, Mazen Ahmed, Christoffer Stark, et al.
Pageof 30